Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Consolidated Net Income: 2020-2025

Historic Consolidated Net Income for Rhythm Pharmaceuticals (RYTM) over the last 5 years, with Sep 2025 value amounting to -$52.9 million.

  • Rhythm Pharmaceuticals' Consolidated Net Income fell 21.23% to -$52.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$192.3 million, marking a year-over-year increase of 25.72%. This contributed to the annual value of -$260.6 million for FY2024, which is 41.11% down from last year.
  • Latest data reveals that Rhythm Pharmaceuticals reported Consolidated Net Income of -$52.9 million as of Q3 2025, which was down 13.45% from -$46.6 million recorded in Q2 2025.
  • In the past 5 years, Rhythm Pharmaceuticals' Consolidated Net Income ranged from a high of $43.8 million in Q1 2021 and a low of -$141.4 million during Q1 2024.
  • In the last 3 years, Rhythm Pharmaceuticals' Consolidated Net Income had a median value of -$46.6 million in 2025 and averaged -$54.0 million.
  • Per our database at Business Quant, Rhythm Pharmaceuticals' Consolidated Net Income soared by 228.06% in 2021 and then crashed by 220.07% in 2022.
  • Rhythm Pharmaceuticals' Consolidated Net Income (Quarterly) stood at -$50.9 million in 2021, then climbed by 16.44% to -$42.5 million in 2022, then increased by 2.02% to -$41.6 million in 2023, then dropped by 3.98% to -$43.3 million in 2024, then declined by 21.23% to -$52.9 million in 2025.
  • Its Consolidated Net Income stands at -$52.9 million for Q3 2025, versus -$46.6 million for Q2 2025 and -$49.5 million for Q1 2025.